Please enable JavaScript to continue using this application.

Compare $HUMA vs $IMDX | Chartloom

Compare

$HUMA vs $IMDX

Humacyte Inc · Insight Molecular Diagnostics Inc

HUMA

Humacyte Inc

IMDX

Insight Molecular Diagnostics Inc

Compare $HUMA vs $IMDX

Comparing Humacyte Inc and Insight Molecular Diagnostics Inc

HUMAHumacyte Inc

IMDXInsight Molecular Diagnostics Inc

HUMAHumacyte Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.62x

Rev growth (TTM)

159.3%

YTD performance

-58.4%

52W performance

-76.0%

FCF yield

-89.3%

IMDXInsight Molecular Diagnostics Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

58.81x

Rev growth (TTM)

-60.8%

YTD performance

-52.9%

52W performance

-8.4%

FCF yield

-28.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HUMA

IMDX

Detailed metrics comparison

HUMA

Humacyte Inc

IMDX

Insight Molecular Diagnostics Inc

Market Cap

HUMA$109M

IMDX$109M

Enterprise Value

HUMA$96M

IMDX$92M

Price

HUMA$0.41

IMDX$3.37

P/E Ratio

HUMAN/A

IMDXN/A

P/S Ratio

HUMA51.53x

IMDX65.16x

EV/Sales

HUMA45.06x

IMDX54.99x

EV/EBITDA

HUMA0.00x

IMDX0.00x

P/B Ratio

HUMA4.63x

IMDX102.52x

P/FCF Ratio

HUMAN/A

IMDXN/A

EV/FCF

HUMA-0.98x

IMDX-2.97x

PEG Ratio

HUMAN/A

IMDXN/A

Forward P/E (NTM)

HUMAN/A

IMDXN/A

Forward P/S (NTM)

HUMA14.62x

IMDX58.81x

Revenue (TTM)

HUMA$2M

IMDX$2M

Revenue Growth (YoY)

HUMA159.3%

IMDX-60.8%

Forward Rev Growth

HUMA520.3%

IMDX593.7%

Gross Margin (TTM)

HUMA-494.6%

IMDX48.3%

Operating Margin (TTM)

HUMA0.0%

IMDX0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

IMDX-1986.2%

Net Margin (TTM)

HUMA-4560.8%

IMDX-2955.6%

FCF Margin (TTM)

HUMA-4599.7%

IMDX-1848.8%

Net Income (TTM)

HUMA$-97M

IMDX$-49M

FCF (TTM)

HUMA$-98M

IMDX$-31M

EPS (TTM)

HUMA-$0.41

IMDX-$1.34

ROE (TTM)

HUMA-51675.0%

IMDX-42668.0%

ROA (TTM)

HUMA-8476.0%

IMDX-14147.0%

ROIC (TTM)

HUMA-9784.0%

IMDX-37415.0%

Cash

HUMA$80M

IMDX$18M

Debt

HUMA$66M

IMDX$766K

Net Cash/Debt

HUMA$14M

IMDX$17M

Current Ratio (TTM)

HUMA6.21x

IMDX2.00x

Quick Ratio (TTM)

HUMA5.38x

IMDX1.82x

Debt/Equity (TTM)

HUMA2.12x

IMDX0.92x

Debt/Assets (TTM)

HUMA0.0%

IMDX0.0%

Interest Coverage (TTM)

HUMAN/A

IMDXN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

IMDX0.00x

Beta

HUMA2.76

IMDX1.86

52W Performance

HUMA-76.0%

IMDX-8.4%

YTD Performance

HUMA-58.4%

IMDX-52.9%

% from 52W High

HUMA-78.6%

IMDX-60.4%

% from 52W Low

HUMA3.7%

IMDX39.3%

Asset Turnover (TTM)

HUMA0.02x

IMDX0.05x

FCF Yield (TTM)

HUMA-89.3%

IMDX-28.4%

Earnings Yield (TTM)

HUMA-88.5%

IMDX-45.4%

Dividend Yield (TTM)

HUMAN/A

IMDXN/A

Rule of 40

HUMA-4,440.4

IMDX-1,909.6

EV/GP/RG

HUMAN/A

IMDX10.54

Ticker research

View HUMA research View IMDX research

Metric	HUMA Humacyte Inc	IMDX Insight Molecular Diagnostics Inc
Market & Valuation
Market Cap	$109M	$109M
Enterprise Value	$96M	$92M
Price	$0.41	$3.37
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	65.16x
EV/Sales	45.06x	54.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	102.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	-2.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	58.81x
Revenue & Growth
Revenue (TTM)	$2M	$2M
Revenue Growth (YoY)	159.3%	-60.8%
Forward Rev Growth	520.3%	593.7%
Profitability
Gross Margin (TTM)	-494.6%	48.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	-1986.2%
Net Margin (TTM)	-4560.8%	-2955.6%
FCF Margin (TTM)	-4599.7%	-1848.8%
Net Income (TTM)	$-97M	$-49M
FCF (TTM)	$-98M	$-31M
EPS (TTM)	-$0.41	-$1.34
ROE (TTM)	-51675.0%	-42668.0%
ROA (TTM)	-8476.0%	-14147.0%
ROIC (TTM)	-9784.0%	-37415.0%
Financial Health
Cash	$80M	$18M
Debt	$66M	$766K
Net Cash/Debt	$14M	$17M
Current Ratio (TTM)	6.21x	2.00x
Quick Ratio (TTM)	5.38x	1.82x
Debt/Equity (TTM)	2.12x	0.92x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	1.86
52W Performance	-76.0%	-8.4%
YTD Performance	-58.4%	-52.9%
% from 52W High	-78.6%	-60.4%
% from 52W Low	3.7%	39.3%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.05x
FCF Yield (TTM)	-89.3%	-28.4%
Earnings Yield (TTM)	-88.5%	-45.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	-1,909.6
EV/GP/RG	N/A	10.54
Ticker research	View HUMA research	View IMDX research

Valuation

P/S Ratio

HUMA

51.53x

IMDX

65.16x

EV/FCF

IMDX

-2.97x

HUMA

-0.98x

Growth & revenue

Revenue Growth TTM

HUMA

159.3%

IMDX

-60.8%

Forward Revenue Growth

IMDX

593.7%

HUMA

520.3%

Profitability & performance

Gross Margin

IMDX

48.3%

HUMA

-494.6%

ROE

IMDX

-42668.0%

HUMA

-51675.0%

FCF Yield %

IMDX

-28.4%

HUMA

-89.3%

52-Week Performance

IMDX

-8.4%

HUMA

-76.0%

Detailed metrics comparison

HUMA

Humacyte Inc

IMDX

Insight Molecular Diagnostics Inc

Market Cap

HUMA$109M

IMDX$109M

Enterprise Value

HUMA$96M

IMDX$92M

Price

HUMA$0.41

IMDX$3.37

P/E Ratio

HUMAN/A

IMDXN/A

P/S Ratio

HUMA51.53x

IMDX65.16x

EV/Sales

HUMA45.06x

IMDX54.99x

EV/EBITDA

HUMA0.00x

IMDX0.00x

P/B Ratio

HUMA4.63x

IMDX102.52x

P/FCF Ratio

HUMAN/A

IMDXN/A

EV/FCF

HUMA-0.98x

IMDX-2.97x

PEG Ratio

HUMAN/A

IMDXN/A

Forward P/E (NTM)

HUMAN/A

IMDXN/A

Forward P/S (NTM)

HUMA14.62x

IMDX58.81x

Revenue (TTM)

HUMA$2M

IMDX$2M

Revenue Growth (YoY)

HUMA159.3%

IMDX-60.8%

Forward Rev Growth

HUMA520.3%

IMDX593.7%

Gross Margin (TTM)

HUMA-494.6%

IMDX48.3%

Operating Margin (TTM)

HUMA0.0%

IMDX0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

IMDX-1986.2%

Net Margin (TTM)

HUMA-4560.8%

IMDX-2955.6%

FCF Margin (TTM)

HUMA-4599.7%

IMDX-1848.8%

Net Income (TTM)

HUMA$-97M

IMDX$-49M

FCF (TTM)

HUMA$-98M

IMDX$-31M

EPS (TTM)

HUMA-$0.41

IMDX-$1.34

ROE (TTM)

HUMA-51675.0%

IMDX-42668.0%

ROA (TTM)

HUMA-8476.0%

IMDX-14147.0%

ROIC (TTM)

HUMA-9784.0%

IMDX-37415.0%

Cash

HUMA$80M

IMDX$18M

Debt

HUMA$66M

IMDX$766K

Net Cash/Debt

HUMA$14M

IMDX$17M

Current Ratio (TTM)

HUMA6.21x

IMDX2.00x

Quick Ratio (TTM)

HUMA5.38x

IMDX1.82x

Debt/Equity (TTM)

HUMA2.12x

IMDX0.92x

Debt/Assets (TTM)

HUMA0.0%

IMDX0.0%

Interest Coverage (TTM)

HUMAN/A

IMDXN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

IMDX0.00x

Beta

HUMA2.76

IMDX1.86

52W Performance

HUMA-76.0%

IMDX-8.4%

YTD Performance

HUMA-58.4%

IMDX-52.9%

% from 52W High

HUMA-78.6%

IMDX-60.4%

% from 52W Low

HUMA3.7%

IMDX39.3%

Asset Turnover (TTM)

HUMA0.02x

IMDX0.05x

FCF Yield (TTM)

HUMA-89.3%

IMDX-28.4%

Earnings Yield (TTM)

HUMA-88.5%

IMDX-45.4%

Dividend Yield (TTM)

HUMAN/A

IMDXN/A

Rule of 40

HUMA-4,440.4

IMDX-1,909.6

EV/GP/RG

HUMAN/A

IMDX10.54

Ticker research

View HUMA research View IMDX research

Metric	HUMA Humacyte Inc	IMDX Insight Molecular Diagnostics Inc
Market & Valuation
Market Cap	$109M	$109M
Enterprise Value	$96M	$92M
Price	$0.41	$3.37
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	65.16x
EV/Sales	45.06x	54.99x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	102.52x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	-2.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	58.81x
Revenue & Growth
Revenue (TTM)	$2M	$2M
Revenue Growth (YoY)	159.3%	-60.8%
Forward Rev Growth	520.3%	593.7%
Profitability
Gross Margin (TTM)	-494.6%	48.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	-1986.2%
Net Margin (TTM)	-4560.8%	-2955.6%
FCF Margin (TTM)	-4599.7%	-1848.8%
Net Income (TTM)	$-97M	$-49M
FCF (TTM)	$-98M	$-31M
EPS (TTM)	-$0.41	-$1.34
ROE (TTM)	-51675.0%	-42668.0%
ROA (TTM)	-8476.0%	-14147.0%
ROIC (TTM)	-9784.0%	-37415.0%
Financial Health
Cash	$80M	$18M
Debt	$66M	$766K
Net Cash/Debt	$14M	$17M
Current Ratio (TTM)	6.21x	2.00x
Quick Ratio (TTM)	5.38x	1.82x
Debt/Equity (TTM)	2.12x	0.92x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	1.86
52W Performance	-76.0%	-8.4%
YTD Performance	-58.4%	-52.9%
% from 52W High	-78.6%	-60.4%
% from 52W Low	3.7%	39.3%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.05x
FCF Yield (TTM)	-89.3%	-28.4%
Earnings Yield (TTM)	-88.5%	-45.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	-1,909.6
EV/GP/RG	N/A	10.54
Ticker research	View HUMA research	View IMDX research